Accelerated Development of Appropriate Patient Therapies
a Sustainable, Multi-stakeholder Approach from Research to Treatment-outcomes
On Friday September 4th, 2015, a coalition of 90 European healthcare stakeholders from 32 organisations including patients, payers, regulators, HTAs, academic institutions, and industry took their first steps towards investigating MAPPs tools and methodologies, and engaging in a dialogue with all relevant stakeholders to prove and develop workable MAPPs concepts. Here is a collection of headlines inspired [...]
The project will establish a platform that enables the coordination of Medicines Adaptive Pathways to Patients (MAPPs) related activities within the Innovative Medicines Initiative (IMI) and engages in dialogue with all relevant stakeholders. MAPPs seek to foster access to beneficial treatments for the right patient groups at the earliest appropriate time in the product life-span in a sustainable fashion. The outcomes of the ADAPT SMART consortium will help inform future research agendas and discuss approaches for the implementation of MAPPs.
The adaptive pathways approach (formerly known as ‘adaptive licensing’) is part of the European Medicines Agency’s (EMA) efforts to improve timely access for patients to new medicines.
The project overview of ADAPT SMART (Accelerated Development of Appropriate Patient Therapies: a Sustainable, Multi-stakeholder Approach from Research to Treatment-outcomes) provides information regarding participants, objectives, expected impact, and a work plan, among other details.
The Innovative Medicines Initiative (IMI) yesterday launched its 5th Call for proposals under the IMI 2 programme.
In this interview, Professor Sarah Garner, Associate Director for Science Policy and Research at NICE, speaks about The GetReal project is another IMI initiative addressing MAPPs. Real world evidence holds the potential to both increase efficiency in R&D and to bridge the gap between the proof of efficacy required to pass regulatory scrutiny and the demonstration of likely effectiveness needed to satisfy health technology assessment bodies.
The inaugural meeting of the NEWDIGS Data Program was held in January 2015, and brought together international experts from academia, government, information technology, and the healthcare sector. A series of panel discussions focused on identifying the gaps and opportunities that might be addressed through better international cooperation in data system design and use.
4th September 2015
European Medicines Agency, London, UK
On the 4th of September, the Consortium participants of the ADAPT SMART project met at the EMA in London. This meeting officially launched the ADAPT SMART collaboration. The ADAPT SMART consortium aims to facilitate and accelerate the availability of MAPPs to all healthcare stakeholders. A full event report with details of the 4th September event is available on the ADAPT SMART website.
